| abstract |
PCT No. PCT/EP95/04770 Sec. 371 Date Jun. 12, 1997 Sec. 102(e) Date Jun. 12, 1997 PCT Filed Dec. 4, 1995 PCT Pub. No. WO96/19209 PCT Pub. Date Jun. 27, 1996The present invention relates to the use of some natural or synthetic chalcones and the esters thereof with straight or branched aliphatic acids, saturated and unsaturated, containing up to 22 carbon atoms in the therapy and prevention of the uterus, ovary and breast tumors, as well as the formulations containing them. Chalcones such as isocordoin, cordoin, 2-hydroxyderricin, 2',4'-dihydroxychalcone, 4,2',4'-trihydroxychalcone have a marked affinity to the estrogen receptors of type II and an antiproliferative activity on uterus, ovary and breast tumor cell lines. These molecules proved to be useful both in therapy and in the prevention of such tumors. |